Advancing Metabolic Syndrome Research

Advancing Metabolic Syndrome Research
Obesity, diabetes and associated conditions, under the umbrella of metabolic syndrome, are urgent health issues. Key features of metabolic syndrome include:
These symptoms are risk factors for atherosclerosis, coronary heart disease, type 2 diabetes, kidney disease, and even premature death.
Metabolism and Endocrinology Biomarkers
Study various biomarkers related to metabolism with Millipore’s wide array of MILLIPLEX MAP multiplex assay panels, ELISAs and RIA kits. Adults with metabolic syndrome show inflammation, whose link with obesity may be dysregulated adipocyte production of pro- and anti-inflammatory factors. Consequently, biomarkers for metabolic syndrome include cytokines, acute phase proteins, diabetes and obesity related hormones, as well as other endocrine biomarkers. Gut hormones regulate gut motility and secretion, pancreatic islet hormone secretion, food intake and energy expenditure. In addition, hormones called adipokines regulate appetite and energy balance, insulin sensitivity, and lipid metabolism. One of these adipokines, adiponectin, has anti-inflammatory effects on the cellular lining of blood vessel walls, which may help to explain the association of high adiponectin levels with a reduced risk of heart attack. With our expanding portfolio of assays to detect endocrine biomarkers, hormones, insulin-like growth factor, bone metabolism, and more, Millipore is the leader in advancing your research of metabolic syndrome.